Muscle invasive bladder cancer (MIBC) can feel overwhelming for patients and families, but advances in treatment are providing new hope. During our Vancouver Bladder Cancer Education Event, held in May of 2025, Dr. Bernie Eigl discusses “The Evolution of the Treatment Landscape in Muscle Invasive Bladder Cancer” with the bladder cancer community and what that means for patients.
Understanding Muscle Invasive Bladder Cancer
MIBC is considered high-risk, but it is still potentially curable. About one in four bladder cancer patients either present with MIBC or progress from non-muscle invasive disease. Early detection and personalized treatment strategies are key to improving outcomes.
Current Treatment Approaches for MIBC
Traditionally, treatment for MIBC focuses on local and systemic therapies:
- Cystectomy: Full bladder removal remains the standard for many patients.
- Tri-modality therapy (TMT): A bladder-sparing option combining surgery, radiation, and chemotherapy.
- Systemic therapy: Neo-adjuvant cisplatin-based chemotherapy before surgery can improve cure rates.
After surgery, the type of residual disease guides next steps. For high-risk patients, immunotherapy, like nivolumab, can significantly improve recurrence-free survival and overall survival.
Emerging Therapies for MIBC
Recent years have brought a wave of promising cancer treatment:
- Immunotherapy: Helps the immune system recognize and attack cancer cells.
- Antibody-drug conjugates (ADCs): Targeted therapies, such as enfortumab vedotin combined with pembrolizumab, have dramatically improved survival in metastatic settings.
- Combination approaches: Pairing chemo with checkpoint inhibitors can boost outcomes for some patients.
- Personalized medicine: Early-stage clinical trials with mRNA vaccines are exploring tailored treatments after surgery.
Tri-modality Therapy: A Bladder-Sparing Option
For those who want to preserve their bladder, TMT offers a carefully coordinated approach: surgical tumor removal, radiation, and radio sensitizing chemotherapy. For the right candidates, outcomes can be similar to cystectomy, giving patients another pathway to recovery.
Looking Ahead and Taking Control of Your Journey with Bladder Cancer Canada
With ongoing clinical trials and research, the future of MIBC treatment is promising. New combinations, immunotherapies, and personalized approaches aim to improve survival while potentially reducing the need for radical surgery.
At Bladder Cancer Canada, we are here to provide trusted education, support programs, and resources to help you stay informed and feel confident about your treatment options.
Explore more resources and connect with our community today.
